Table 1 Analysis of CAT-13–treated mice... | American Society of Hematology

Table 1

Analysis of CAT-13–treated mice survival after tumor inoculation and tumor challenge

Independent experiment no.	CAT-13–treated mice		CAT-13–treated surviving mice challenged at day 70
Independent experiment no.	Survivors*/total	Overall survival, percentage	Survivors†/total	Overall survival, percentage
1	8/12	66.7	4/7	57.1
2	7/12	58.3	2/7	28.6
3	10/16	62.5	1/5	20.0
4	14/17	82.4	5/7	71.4
5	8/15	53.3	3/7	42.8
6	10/18	55.6	2/5	40.0
7	6/8	75.0	3/6	50.0
Survivors/total	63/98	—	20/44	—
Mean ± SD, percentage	—	64.2 ± 10.6	—	44.2 ± 17.2

Independent experiment no.	CAT-13–treated mice		CAT-13–treated surviving mice challenged at day 70
Independent experiment no.	Survivors*/total	Overall survival, percentage	Survivors†/total	Overall survival, percentage
1	8/12	66.7	4/7	57.1
2	7/12	58.3	2/7	28.6
3	10/16	62.5	1/5	20.0
4	14/17	82.4	5/7	71.4
5	8/15	53.3	3/7	42.8
6	10/18	55.6	2/5	40.0
7	6/8	75.0	3/6	50.0
Survivors/total	63/98	—	20/44	—
Mean ± SD, percentage	—	64.2 ± 10.6	—	44.2 ± 17.2

Data are from 7 independent experiments with or without tumor challenge.

— indicates not applicable.

Number of surviving CAT-13–treated mice 70 days after inoculation of tumor cells on day 0.

Number of surviving CAT-13–treated mice 70 days after a tumor challenge on day 70.